Clinical Trial Update: A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B) [Phase 2]

View source ↗

Summary

Phase 2 SABRE-B trial evaluating sunitinib in combination with bevacizumab and paclitaxel for previously untreated metastatic breast cancer. The study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Sutent (sunitinib)
• Taxol (paclitaxel)

Snippet

Sponsor: Genentech, Inc. | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2009-12-03